Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity

RT @CVIR_Journal: Throwback Thursday #Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multi…

Throwback Thursday #Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity | https://t.co/BFzE23XSiE #IRad https://t.co/O8JksSjWp2

In case you missed it, here is the 2020 Editors' Medal award winning article https://t.co/BFzE23XSiE - enjoy the read! #irad https://t.co/rQF4e70T4Q

RT @SirtexMedical: The @CVIR_Journal of @cirsesociety received 1,200 papers in 2019. We're thrilled that a global multicenter study of SIR-…

The @CVIR_Journal of @cirsesociety received 1,200 papers in 2019. We're thrilled that a global multicenter study of SIR-Spheres® #Y90 microspheres use in #LiverCancer was a winning submission, earning Editors' Medal 2020. Read the study here: https://t.co/

RT @SirtexMedical: Exciting news! A global study of SIR-Spheres® #Y90 microspheres use in #LiverCancer treatment was awarded the Editors’ M…

RT @SirtexMedical: Exciting news! A global study of SIR-Spheres® #Y90 microspheres use in #LiverCancer treatment was awarded the Editors’ M…

Exciting news! A global study of SIR-Spheres® #Y90 microspheres use in #LiverCancer treatment was awarded the Editors’ Medal 2020 from @CVIR_Journal of @cirsesociety. Congratulations to the entire team for their work. Read the study here: https://t.co/kVJf

RT @CVIR_Journal: CVIR proudly presents: the winner of the EDITORS' MEDAL 2020 🏅🏅🏅🏅🏅 Radioembolization With 90 Y Resin Microspheres of Neu…

CVIR proudly presents: the winner of the EDITORS' MEDAL 2020 🏅🏅🏅🏅🏅 Radioembolization With 90 Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity https://t.co/zE1zinRLmo https://t.co/FMiBN03EZJ

RT @CVIR_Journal: #TBT2020 Multicenter study! Safety and efficacy of radioembolization in NEN patients confirmed with a high disease contro…

#TBT2020 Multicenter study! Safety and efficacy of radioembolization in NEN patients confirmed with a high disease control rate of 91% in progressive patients, and alleviation of NEN-related symptoms in 79% of symptomatic patients. https://t.co/Kcpzem9rc3

RT @CVIR_Journal: Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Effi…

RT @CVIR_Journal: Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Effi…

RT @CVIR_Journal: Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Effi…

RT @CVIR_Journal: Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Effi…

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity https://t.co/ICkYWL0B6K https://t.co/ZYKEafTto8

March Editor's Choice: Yttrium-90 for NET: Satisfactory results with median overall survival of 2.6 years & < 4% treatment-specific complications from this study on 244 NEN patients treated with 90Y resin microspheres: https://t.co/7yQD4YMYHv #IRad